KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Change in Acquisitions & Divestments: 2013-2025

Historic Change in Acquisitions & Divestments for Halozyme Therapeutics (HALO) over the last 12 years, with Sep 2025 value amounting to $209.6 million.

  • Halozyme Therapeutics' Change in Acquisitions & Divestments rose 51.87% to $209.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $532.8 million, marking a year-over-year increase of 62.85%. This contributed to the annual value of $395.6 million for FY2024, which is 87.21% up from last year.
  • According to the latest figures from Q3 2025, Halozyme Therapeutics' Change in Acquisitions & Divestments is $209.6 million, which was up 10.83% from $189.1 million recorded in Q2 2025.
  • In the past 5 years, Halozyme Therapeutics' Change in Acquisitions & Divestments ranged from a high of $590.0 million in Q2 2022 and a low of $15.6 million during Q4 2023.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $81.2 million (2023), whereas its average is $96.0 million.
  • As far as peak fluctuations go, Halozyme Therapeutics' Change in Acquisitions & Divestments surged by 667.59% in 2022, and later tumbled by 90.95% in 2023.
  • Quarterly analysis of 5 years shows Halozyme Therapeutics' Change in Acquisitions & Divestments stood at $69.8 million in 2021, then plummeted by 71.18% to $20.1 million in 2022, then dropped by 22.52% to $15.6 million in 2023, then spiked by 438.34% to $84.0 million in 2024, then skyrocketed by 51.87% to $209.6 million in 2025.
  • Its Change in Acquisitions & Divestments was $209.6 million in Q3 2025, compared to $189.1 million in Q2 2025 and $50.2 million in Q1 2025.